J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)

BOM:506943 Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	882.15	769.34	565.44	286.86	290.08
Short-Term Investments	67.7	0.85	1.06	-	-
Trading Asset Securities	3,647	1,922	-	6,650	3,338
Cash & Short-Term Investments	4,596	2,692	566.5	6,937	3,628
Cash Growth	70.74%	375.20%	-91.83%	91.19%	-9.08%
Accounts Receivable	6,869	5,758	5,557	3,890	3,454
Other Receivables	160.06	275.92	411.27	290.23	109.08
Receivables	7,036	6,048	5,981	4,185	3,614
Inventory	5,025	4,305	4,100	3,474	2,747
Prepaid Expenses	163.23	167.05	120.4	122.56	79.82
Other Current Assets	1,713	2,069	1,764	807.15	663.26
Total Current Assets	18,533	15,280	12,532	15,526	10,732
Property, Plant & Equipment	6,349	5,764	5,668	5,697	5,842
Long-Term Investments	237.08	137.84	127.22	129.09	694.55
Goodwill	574.59	574.59	574.59	574.59	531.4
Other Intangible Assets	13,885	13,223	6,714	321.05	300.92
Long-Term Deferred Tax Assets	58.78	65.1	64.31	69.43	65.78
Other Long-Term Assets	298.2	486.97	386.74	58.93	14.2
Total Assets	39,941	35,539	26,074	22,381	18,206
Accounts Payable	3,563	2,386	2,245	1,869	1,680
Accrued Expenses	167.83	176.15	247.43	241.37	71.36
Short-Term Debt	153.43	280.18	263.15	326.45	294.94
Current Portion of Long-Term Debt	3,182	1,370	-	-	-
Current Portion of Leases	108.77	88.87	76.26	72.02	49.53
Current Income Taxes Payable	117.62	49.54	60.95	79.02	60.21
Current Unearned Revenue	12.19	11.83	17.06	16.6	16.49
Other Current Liabilities	1,378	1,181	927.51	848.05	960.51
Total Current Liabilities	8,682	5,544	3,837	3,453	3,133
Long-Term Debt	236.39	3,832	-	-	-
Long-Term Leases	96.38	153.21	206.18	51.41	12.29
Long-Term Unearned Revenue	16.99	24.93	31.66	49.32	59.68
Long-Term Deferred Tax Liabilities	1,492	1,028	475.59	567.67	547.18
Other Long-Term Liabilities	183.26	146.1	132.19	112.09	73.87
Total Liabilities	10,708	10,735	4,688	4,247	3,826
Common Stock	155.2	154.76	154.56	154.56	154.56
Additional Paid-In Capital	1,134	697.02	507.68	507.68	507.68
Retained Earnings	26,676	22,757	19,933	17,354	13,734
Comprehensive Income & Other	1,268	1,195	745.66	80.81	-41.06
Total Common Equity	29,233	24,804	21,341	18,097	14,355
Minority Interest	-	-	44.9	37.05	25.01
Shareholders' Equity	29,233	24,804	21,386	18,134	14,380
Total Liabilities & Equity	39,941	35,539	26,074	22,381	18,206
Total Debt	3,777	5,724	545.59	449.88	356.76
Net Cash (Debt)	819.79	-3,032	20.92	6,487	3,271
Net Cash Growth	-	-	-99.68%	98.28%	-12.35%
Net Cash Per Share	5.17	-19.36	0.14	41.97	20.56
Filing Date Shares Outstanding	155.19	154.76	154.56	154.56	154.56
Total Common Shares Outstanding	155.19	154.76	154.56	154.56	154.56
Working Capital	9,851	9,736	8,694	12,073	7,599
Book Value Per Share	188.37	160.28	138.07	117.09	92.87
Tangible Book Value	14,774	11,006	14,053	17,202	13,523
Tangible Book Value Per Share	95.20	71.12	90.92	111.29	87.49
Land	335.72	5.72	5.72	5.72	5.72
Buildings	3,111	2,925	2,833	2,696	2,715
Machinery	8,760	8,363	8,095	7,800	7,863
Construction In Progress	633.22	444.09	139.06	255.67	161.67

Source: S&P Global Market Intelligence. Standard template. Financial Sources.